Phase II Study of Sorafenib/Avastin as Salvage Therapy in Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Bevacizumab (Primary) ; Sorafenib (Primary)
- Indications Colon cancer; Rectal cancer
- Focus Biomarker; Therapeutic Use
- 07 Aug 2017 Status changed from active, no longer recruiting to completed.
- 06 Feb 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Jun 2012 Actual end date Jan 2010 added as reported by ClinicalTrials.gov.